Methane
Preclinical / discovery stageRecent clinical, regulatory, research and industry developments relating to this drug.
Low methane emissions following experimental bog rewetting
Methane emissions remain flat even as biggest US oil region opens the tap
Fully implementing methane plans could reverse emissions growth but miss 2030 target
Evaluating space-based methane detection through a one-year blind test
Large blind test of methane-detecting satellites lends credibility to emissions data
Methane bursts during spring thaw in the permafrost region of Northeast China
Recent findings in methanotrophs: genetics, molecular ecology, and biopotential.
Microbial methane cycling in a landfill on a decadal time scale.
Environmental Sustainability Impacts of Solid Waste Management Practices in the Global South.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- Nature communications2
- Annual review of microbiology1
- Applied microbiology and biotechnology1
- International journal of environmental research and public health1
- Nature microbiology1
- Abubakar IR1
- Ahmadi F1
- Ahmed SMS1
- Al-Gehlani WAG1
- Alrawaf TI1
- AlShammari MS1
- AlShihri FS1
- Boetius A1
- Ann Romney Center for Neurologic Diseases1
- Carleton University1
- Center for Clinical and Translational Metagenomics1
- Center for Microbiology1
- College of Architecture and Planning1
- Herlev-Gentofte Hospital1
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature